3

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: July 8, 2024
Period of Report: July 8, 2024
Accession Number: 0001127602-24-020201

View Document ↗ View on SEC.gov ↗